KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Intangibles (2021 - 2025)

Pacific Biosciences Of California has reported Intangibles over the past 5 years, most recently at $15.1 million for Q4 2025.

  • Quarterly results put Intangibles at $15.1 million for Q4 2025, down 96.12% from a year ago — trailing twelve months through Dec 2025 was $15.1 million (down 96.12% YoY), and the annual figure for FY2025 was $15.1 million, down 96.12%.
  • Intangibles for Q4 2025 was $15.1 million at Pacific Biosciences Of California, down from $16.1 million in the prior quarter.
  • Over the last five years, Intangibles for PACB hit a ceiling of $461.8 million in Q3 2023 and a floor of $15.1 million in Q4 2025.
  • Median Intangibles over the past 5 years was $410.3 million (2022), compared with a mean of $332.1 million.
  • Biggest five-year swings in Intangibles: rose 12.56% in 2023 and later tumbled 96.3% in 2025.
  • Pacific Biosciences Of California's Intangibles stood at $411.0 million in 2021, then fell by 0.18% to $410.2 million in 2022, then grew by 11.39% to $457.0 million in 2023, then dropped by 14.75% to $389.6 million in 2024, then tumbled by 96.12% to $15.1 million in 2025.
  • The last three reported values for Intangibles were $15.1 million (Q4 2025), $16.1 million (Q3 2025), and $17.2 million (Q2 2025) per Business Quant data.